Cyril Laurent

Cyril Laurent is a Scientist II at Altasciences where Cyril manages and conducts method development, qualification, and production studies for clinical and non-clinical studies. Prior to this, Cyril worked as a Principal Scientist at CellCarta, focusing on immuno-oncology studies, and as a Post-Doctoral Researcher at Centre de recherche du CHUM and INSERM, where Cyril studied the impact of interleukin IL-15 on Multiple Sclerosis and the progression of Alzheimer's Disease, respectively. Cyril holds a PhD in Biomolecules, Pharmacology, Therapeutics, and Neuroscience from the University of Lille 1 Sciences and Technology, along with a Master's degree in Biology & Health and a Bachelor's degree in Cellular Biology and Physiology.